scholarly journals Optimal cut-off threshold in pulse pressure predicting cardiovascular death among newly diagnosed end-stage renal disease patients

Medicine ◽  
2019 ◽  
Vol 98 (27) ◽  
pp. e16340
Author(s):  
Zheng Wang ◽  
Dahai Yu ◽  
Yamei Cai ◽  
Bin Zhao ◽  
Xiaoxue Zhang ◽  
...  
2016 ◽  
Vol 68 (3) ◽  
pp. 357-365 ◽  
Author(s):  
Laura Plantinga ◽  
S. Sam Lim ◽  
Rachel Patzer ◽  
William McClellan ◽  
Michael Kramer ◽  
...  

2018 ◽  
Vol 7 (11) ◽  
pp. 388
Author(s):  
Ming-Ju Wu ◽  
Tung-Min Yu ◽  
Cheng-Li Lin ◽  
Chia-Hung Kao

Background: Several comparison studies have suggested that kidney transplantation (KT) could reduce mortality in patients with end-stage renal disease (ESRD). Selection criteria bias is common in the selection of dialysis patients for control groups. In this study, we compared the survival outcome between KT recipients and comparable propensity score-matched dialysis patients. Methods: We used Taiwan’s National Health Insurance Research Database to identify patients newly diagnosed with ESRD between 2000 and 2010. We separated them into two groups: a KT group and non-KT dialysis-only group. To evaluate the survival outcome, we compared each patient with KT to a patient on dialysis without KT using propensity score matching. Results: In total, 1276 KT recipients and 1276 propensity score-matched dialysis patients were identified. Compared with the propensity score-matched dialysis patients, the patients who underwent KT exhibited significantly higher 5-year and 10-year survival rates (88% vs. 92% and 74% vs. 87%, both p < 0.05). The crude and adjusted hazard ratios for mortality were 0.55 and 0.52 in patients with KT (both p < 0.001). Mortality was insignificantly higher for patients who were on dialysis for longer than 1 year prior to KT compared with those on dialysis for less than 1 year. Conclusion: This study used a propensity score-matched cohort to confirm that KT is associated with lower risk of mortality than dialysis alone in patients newly diagnosed with ESRD.


2021 ◽  
Vol 59 (233) ◽  
Author(s):  
Madhav Ghimire ◽  
Shreeju Vaidya ◽  
Hari Prasad Upadhyay

Introduction: End-stage renal disease patients are in rising trend globally, and they have been foundto occur predominantly in developing countries. Many studies have been published before, withinand across the countries, to know the clinicodemographic profile of end-stage renal disease patients.However, no such studies were done in Chitwan, Nepal. This study’s main objective was to find theprevalence of newly diagnosed end-stage renal disease patients. Methods: A hospital-based descriptive cross-sectional study was carried out in the Department ofNephrology from May 2016 to April 2019. Convenient sampling was done, and all the consecutivenew end-stage renal disease patients were included in the study. The ethical approval was takenfrom the Institutional Review Committee (reference number. 2016/COMSTH/IRC/042). Theprevalence and demographic profile of new end-stage renal disease patients were studied. The datawere analyzed with appropriate statistical tools. Results: A total of 250 new end-stage renal disease patients were found among 2200 admittedpatients. The prevalence of new end-stage renal disease was found to be 250 (11.36%). Out of 250patients, males were 156 (62.4%), and females were 94 (37.6%). The mean age was 49.6±15.5 years. Thecommonest cause of the incident end-stage renal disease was Type 2 Diabetes mellitus 89 (35.6%). Conclusions: The prevalence of new end-stage renal disease was found to be quite high. Thecommonest cause of the incident end-stage renal disease was Type 2 Diabetes Mellitus.


Hypertension ◽  
2002 ◽  
Vol 39 (3) ◽  
pp. 735-738 ◽  
Author(s):  
Michel E. Safar ◽  
Jacques Blacher ◽  
Bruno Pannier ◽  
Alain P. Guerin ◽  
Sylvain J. Marchais ◽  
...  

Author(s):  
Keiichi Sumida ◽  
Joseph F. Pierre ◽  
Zhongji Han ◽  
Tahliyah S. Mims ◽  
Praveen Kumar Potukuchi ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 154
Author(s):  
Eun Hui Bae ◽  
Tae Ryom Oh ◽  
Sang Heon Suh ◽  
Eun Mi Yang ◽  
Hong Sang Choi ◽  
...  

Weight variability has known as a risk factor for cardiovascular events and mortality. However, its effect on end-stage renal disease (ESRD) development remains controversial. We investigated the relationship between weight change and ESRD risk. Overall, 97,029 patients with DM aged >20 years were selected from the Korean National Health Screening Program 2009–2012. Weight change was defined as differences in body weight from the index year to 2 years later. Newly diagnosed ESRD was observed until 2017 end. Over a 5.1-year median follow-up period, ESRD was newly diagnosed in 7932 (4.81%) DM patients. BMI < 18.5 kg/m2 and waist circumferences <85/80 and >100/95 cm were ESRD risk factors. ESRD risk increased with increasing weight change; ≥10% weight loss (hazard ratio [HR], 1.247) followed by ≥10% weight gain (1.247) was associated with a higher HR than ≤5% weight change after adjusting for several confounding factors. The association between weight change and ESRD risk in a subgroup analysis was significantly stronger in patients aged <65 years, without proteinuria, with BMI ≥ 25, with DM duration <5 years, and prescribed less than 3 classes of DM medication. Underweight patients showed higher ESRD risks than overweight patients. Weight loss >10% was associated with the fastest decline in renal function.


Sign in / Sign up

Export Citation Format

Share Document